Advertisement

Topics

U.S. General Anesthesia Drugs Market 2015-2020 - Molecule, Route of Administration, Supply Chain & Competitive Analysis for the $2 Billion Industry

20:00 EDT 4 Aug 2015 | Globe Newswire

Dublin, Aug. 05, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/sg9cwn/u_s_general) has announced the addition of the "U.S. General Anesthesia Drugs Market by Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), route of administration (Intravenous, Inhalational), Supply Chain (GPOs, Distributors), Competitive - Analysis Forecast to 2020" report to their offering.

The U.S. general anesthesia drugs market is poised to reach USD 2.0 Billion by 2020 from USD 1.6 Billion in 2015, at a CAGR of 3.8% from 2015 to 2020.

Factors such as rapid rise in aging population, rising prevalence of cardiovascular and respiratory system-related diseases, and rising number of emergency surgeries are key factors driving the growth of the U.S. general anesthesia drugs market. However, side effects associated with ketamine usage (such as elevation in blood pressure and heart rate, amnesia, respiratory depression, and hallucinations), regulatory issues, and lower compliance rates in comparison with other anesthetic drugs are likely to restrain the growth of this market.

The U.S. general anesthesia drugs market is segmented on the basis of molecule and route of administration. On the basis of molecule, the market is segmented into Propofol, Benzodiazepine, Ketamine (S-(+)-Ketamine HCL), and Methohexital Sodium. Propofol is expected to be fastest-growing segment, owing to its greater preference and rapid onset of action.

On the basis of route of administration, the U.S. general anesthesia drugs market is bifurcated into intravenous and inhalational. The intravenous segment is expected to account for the largest share of the market in 2015. Greater patient compliance and less number of side effects as compared to inhalational anesthetics are driving the growth of the market.

Key players operating in the U.S. general anesthesia drugs market are AstraZeneca plc (U.K.), Baxter International Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Mylan N.V. (U.S.), Eisai Co., Ltd. (Japan), Fresenius Se & Co. KGaA (Germany), Hospira, Inc. (U.S.), and Par Pharmaceutical Companies, Inc. (U.S.).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Market Overview

4 Distribution Structure

5 Product Analysis

6 U.S. General Anesthesia Drugs Market: Key Information

7 Strategic Recommendations for Entering the U.S. General Anesthesia Drugs Market

8 Company Profiles

- Abbott Laboratories
- Astrazeneca PLC
- Baxter International Inc.
- Eisai Co., Ltd.
- Fresenius Se & Co. Kgaa
- Hikma Pharmaceuticals PLC
- Hospira, Inc.
- Mylan N.V.
- Par Pharmaceutical Companies, Inc.

For more information visit http://www.researchandmarkets.com/research/sg9cwn/u_s_general




CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Healthcare and Medical Devices

Primary Logo

NEXT ARTICLE

More From BioPortfolio on "U.S. General Anesthesia Drugs Market 2015-2020 - Molecule, Route of Administration, Supply Chain & Competitive Analysis for the $2 Billion Industry"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Anesthesia
Anesthesia is the loss of feeling or sensation in all or part of the body. It may result from damage to nerves or can be induced by an anesthetist (a medical professional) using anesthetics such as thiopental or propofol or sevoflurane during a surgical ...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...